Share Price and Basic Stock Data
Last Updated: November 14, 2025, 11:15 pm
| PEG Ratio | 0.69 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Balmer Lawrie Investment Ltd operates in the Non-Banking Financial Company (NBFC) sector, with a current market capitalization of ₹1,758 Cr and a share price standing at ₹79.2. The company reported total sales of ₹2,335 Cr for the fiscal year ending March 2023, reflecting a growth from ₹2,074 Cr in March 2022. The revenue trajectory has shown consistent improvement, with sales increasing to ₹2,373 Cr in March 2024 and projected at ₹2,545 Cr for March 2025. Quarterly sales figures also indicate resilience, with Q1 FY 2025 sales at ₹683 Cr, marking an upward trend. The sales figures demonstrate the company’s ability to generate revenue even amidst economic fluctuations, positioning it favorably against typical sector ranges, where revenue growth can often be more volatile. The operating profit margin (OPM) stood at 14% for FY 2025, indicating effective cost management strategies in place. The company’s focus on maintaining robust sales growth amidst rising operational costs is a testament to its effective business model.
Profitability and Efficiency Metrics
The profitability metrics of Balmer Lawrie Investment Ltd reveal a stable performance, with a reported net profit of ₹271 Cr for the trailing twelve months (TTM). This marked an increase from ₹172 Cr in the previous fiscal year, showcasing a continued improvement in profitability. The company’s return on equity (ROE) stood at 13.2%, while the return on capital employed (ROCE) was reported at 17.2%, both figures indicating efficient utilization of shareholders’ funds and capital. The interest coverage ratio (ICR) of 14.04x further illustrates the company’s ability to meet its interest obligations comfortably, which is significantly higher than the typical sector average. Operating profit margins have also displayed an upward trend, reaching 14% in FY 2025, which is indicative of effective operational management. However, the cash conversion cycle of 46 days suggests room for improvement in working capital management, as it is higher than what is typically observed in the sector.
Balance Sheet Strength and Financial Ratios
Balmer Lawrie Investment Ltd maintains a robust balance sheet characterized by total assets of ₹3,204 Cr and total borrowings of only ₹106 Cr, resulting in a low debt-to-equity ratio of 0.05x. This strong financial positioning allows the company to leverage its assets efficiently while minimizing financial risk. The reserves have grown to ₹1,354 Cr, indicating a solid buffer for future investments and potential downturns. The price-to-book value (P/BV) ratio is reported at 1.09x, suggesting that the stock is fairly valued compared to its book value. Furthermore, the current ratio of 2.49x indicates strong liquidity, ensuring that the company can comfortably meet its short-term obligations. However, the increase in other liabilities, which stood at ₹1,723 Cr, poses a potential risk if not managed properly. Overall, the financial ratios reflect a healthy balance sheet, but vigilance regarding rising liabilities is essential.
Shareholding Pattern and Investor Confidence
The shareholding structure of Balmer Lawrie Investment Ltd shows a significant degree of stability, with promoters holding 59.67% of the company’s equity. This high level of promoter ownership is generally perceived as a positive signal for investor confidence, as it indicates alignment of interests between management and shareholders. Institutional investors, including foreign institutional investors (FIIs) and domestic institutional investors (DIIs), hold a minor stake, with FIIs at 1.10% and DIIs at 0.03% as of the latest reporting. The public shareholding accounted for 39.19%, with the total number of shareholders reported at 51,431. This diverse shareholder base can provide a level of support for the stock price. However, the relatively low institutional ownership could indicate limited market interest, which may affect liquidity. Active engagement strategies may be necessary to attract more institutional investors and enhance market perception.
Outlook, Risks, and Final Insight
Looking ahead, Balmer Lawrie Investment Ltd is positioned for continued growth, bolstered by its solid revenue trends and financial health. However, potential risks include rising operational costs that could impact profit margins and the increasing burden of other liabilities, which could affect overall financial stability if not managed prudently. Additionally, while the low debt levels are advantageous, the company must remain vigilant about maintaining this balance amid potential expansion plans. Strengths such as strong profitability metrics and a stable shareholding structure provide a solid foundation for growth. In scenarios where operational efficiencies are improved and costs are controlled, the company could enhance its margins further. Conversely, failure to address rising liabilities could pose challenges to its financial health. Overall, Balmer Lawrie Investment Ltd presents a compelling case for investment, contingent upon its ability to navigate these risks effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Balmer Lawrie Investment Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 11.3 Cr. | 1.13 | 1.91/0.89 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 11.3 Cr. | 1.13 | 11.5/1.03 | 33.4 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 472 Cr. | 144 | 269/130 | 80.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 15.1 Cr. | 16.5 | 37.9/15.0 | 11.3 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 43.9 Cr. | 97.5 | 180/90.0 | 23.4 | 238 | 1.03 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 28,442.12 Cr | 472.90 | 112.86 | 518.50 | 0.21% | 15.80% | 8.84% | 8.50 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 649 | 553 | 516 | 610 | 594 | 587 | 587 | 579 | 641 | 642 | 633 | 611 | 683 |
| Expenses | 587 | 513 | 464 | 556 | 528 | 511 | 511 | 485 | 574 | 569 | 547 | 514 | 598 |
| Operating Profit | 62 | 40 | 52 | 55 | 67 | 77 | 76 | 94 | 66 | 73 | 86 | 97 | 86 |
| OPM % | 10% | 7% | 10% | 9% | 11% | 13% | 13% | 16% | 10% | 11% | 14% | 16% | 13% |
| Other Income | 24 | 24 | 15 | 35 | 24 | 28 | 27 | 30 | 31 | 29 | 22 | 33 | 25 |
| Interest | 5 | 4 | 5 | 5 | 6 | 5 | 5 | 6 | 6 | 5 | 9 | 6 | 7 |
| Depreciation | 14 | 14 | 14 | 14 | 15 | 14 | 14 | 15 | 14 | 14 | 15 | 16 | 14 |
| Profit before tax | 68 | 46 | 47 | 70 | 70 | 85 | 83 | 103 | 76 | 82 | 84 | 107 | 89 |
| Tax % | 17% | 24% | 22% | 38% | 18% | 25% | 19% | 27% | 15% | 24% | 24% | 30% | 22% |
| Net Profit | 56 | 35 | 37 | 44 | 57 | 64 | 68 | 75 | 65 | 63 | 64 | 75 | 69 |
| EPS in Rs | 1.60 | 1.02 | 1.10 | 1.27 | 1.66 | 1.83 | 1.94 | 2.14 | 1.86 | 1.82 | 1.88 | 2.17 | 2.01 |
Last Updated: August 19, 2025, 10:45 pm
Below is a detailed analysis of the quarterly data for Balmer Lawrie Investment Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 683.00 Cr.. The value appears strong and on an upward trend. It has increased from 611.00 Cr. (Mar 2025) to 683.00 Cr., marking an increase of 72.00 Cr..
- For Expenses, as of Jun 2025, the value is 598.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 514.00 Cr. (Mar 2025) to 598.00 Cr., marking an increase of 84.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 86.00 Cr.. The value appears to be declining and may need further review. It has decreased from 97.00 Cr. (Mar 2025) to 86.00 Cr., marking a decrease of 11.00 Cr..
- For OPM %, as of Jun 2025, the value is 13.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Mar 2025) to 13.00%, marking a decrease of 3.00%.
- For Other Income, as of Jun 2025, the value is 25.00 Cr.. The value appears to be declining and may need further review. It has decreased from 33.00 Cr. (Mar 2025) to 25.00 Cr., marking a decrease of 8.00 Cr..
- For Interest, as of Jun 2025, the value is 7.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 14.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 89.00 Cr.. The value appears to be declining and may need further review. It has decreased from 107.00 Cr. (Mar 2025) to 89.00 Cr., marking a decrease of 18.00 Cr..
- For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 30.00% (Mar 2025) to 22.00%, marking a decrease of 8.00%.
- For Net Profit, as of Jun 2025, the value is 69.00 Cr.. The value appears to be declining and may need further review. It has decreased from 75.00 Cr. (Mar 2025) to 69.00 Cr., marking a decrease of 6.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.01. The value appears to be declining and may need further review. It has decreased from 2.17 (Mar 2025) to 2.01, marking a decrease of 0.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:50 am
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,817 | 1,573 | 1,563 | 2,074 | 2,335 | 2,373 | 2,545 | 2,566 |
| Expenses | 1,547 | 1,347 | 1,413 | 1,883 | 2,110 | 2,024 | 2,193 | 2,227 |
| Operating Profit | 270 | 226 | 150 | 191 | 225 | 349 | 352 | 339 |
| OPM % | 15% | 14% | 10% | 9% | 10% | 15% | 14% | 13% |
| Other Income | 58 | 59 | 79 | 65 | 81 | 52 | 85 | 107 |
| Interest | 7 | 15 | 12 | 14 | 18 | 22 | 27 | 29 |
| Depreciation | 30 | 52 | 55 | 57 | 57 | 59 | 60 | 62 |
| Profit before tax | 290 | 218 | 162 | 186 | 232 | 319 | 350 | 356 |
| Tax % | 30% | 26% | 26% | 26% | 26% | 24% | 24% | |
| Net Profit | 202 | 161 | 121 | 137 | 172 | 242 | 267 | 265 |
| EPS in Rs | 5.79 | 4.76 | 3.59 | 3.97 | 5.00 | 6.96 | 7.73 | 7.72 |
| Dividend Payout % | 59% | 79% | 106% | 75% | 66% | 55% | 56% |
YoY Net Profit Growth
| Year | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -20.30% | -24.84% | 13.22% | 25.55% | 40.70% | 10.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -4.55% | 38.07% | 12.32% | 15.15% | -30.37% |
Balmer Lawrie Investment Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 7% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 26% |
| TTM: | 2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 18% |
| 3 Years: | 30% |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 12% |
| Last Year: | 13% |
Last Updated: September 5, 2025, 2:36 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 56 | 63 | 67 | 55 | 56 | 66 | 69 |
| Inventory Days | 47 | 58 | 58 | 51 | 47 | 47 | 43 |
| Days Payable | 0 | 88 | 99 | 68 | 69 | 75 | 66 |
| Cash Conversion Cycle | 102 | 33 | 27 | 38 | 35 | 37 | 46 |
| Working Capital Days | 42 | 51 | 32 | 51 | 41 | 42 | 62 |
| ROCE % | 13% | 9% | 11% | 13% | 17% | 17% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 7.73 | 75.68 | 49.98 | 39.88 | 35.92 |
| Diluted EPS (Rs.) | 7.73 | 75.68 | 49.98 | 39.88 | 35.92 |
| Cash EPS (Rs.) | 11.82 | 119.31 | 75.86 | 66.88 | 64.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 61.98 | 549.97 | 500.91 | 788.73 | 777.64 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 61.98 | 549.97 | 500.91 | 788.73 | 777.64 |
| Revenue From Operations / Share (Rs.) | 113.81 | 1057.87 | 1048.95 | 928.38 | 692.07 |
| PBDIT / Share (Rs.) | 16.78 | 164.10 | 110.61 | 94.86 | 88.56 |
| PBIT / Share (Rs.) | 14.06 | 137.44 | 85.02 | 69.73 | 63.78 |
| PBT / Share (Rs.) | 12.87 | 127.51 | 76.94 | 63.60 | 58.41 |
| Net Profit / Share (Rs.) | 9.10 | 92.65 | 50.28 | 41.74 | 39.62 |
| NP After MI And SOA / Share (Rs.) | 7.73 | 75.68 | 49.98 | 39.88 | 35.92 |
| PBDIT Margin (%) | 14.74 | 15.51 | 10.54 | 10.21 | 12.79 |
| PBIT Margin (%) | 12.35 | 12.99 | 8.10 | 7.51 | 9.21 |
| PBT Margin (%) | 11.30 | 12.05 | 7.33 | 6.85 | 8.43 |
| Net Profit Margin (%) | 7.99 | 8.75 | 4.79 | 4.49 | 5.72 |
| NP After MI And SOA Margin (%) | 6.79 | 7.15 | 4.76 | 4.29 | 5.18 |
| Return on Networth / Equity (%) | 12.47 | 13.76 | 9.97 | 7.92 | 7.26 |
| Return on Capital Employeed (%) | 12.47 | 13.21 | 8.76 | 7.56 | 7.09 |
| Return On Assets (%) | 5.36 | 5.55 | 3.96 | 3.43 | 3.15 |
| Long Term Debt / Equity (X) | 0.05 | 0.05 | 0.07 | 0.07 | 0.08 |
| Total Debt / Equity (X) | 0.05 | 0.06 | 0.08 | 0.08 | 0.08 |
| Asset Turnover Ratio (%) | 0.81 | 0.80 | 0.86 | 0.05 | 0.06 |
| Current Ratio (X) | 2.49 | 2.29 | 2.29 | 2.54 | 2.51 |
| Quick Ratio (X) | 2.22 | 2.02 | 1.98 | 2.16 | 2.20 |
| Inventory Turnover Ratio (X) | 13.09 | 11.79 | 7.88 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 49.14 | 43.60 | 60.02 | 95.29 | 104.40 |
| Dividend Payout Ratio (CP) (%) | 36.37 | 32.24 | 39.70 | 58.45 | 61.77 |
| Earning Retention Ratio (%) | 50.86 | 56.40 | 39.98 | 4.71 | -4.40 |
| Cash Earning Retention Ratio (%) | 63.63 | 67.76 | 60.30 | 41.55 | 38.23 |
| Interest Coverage Ratio (X) | 14.04 | 16.52 | 13.69 | 15.49 | 16.50 |
| Interest Coverage Ratio (Post Tax) (X) | 8.62 | 10.33 | 7.22 | 7.82 | 8.38 |
| Enterprise Value (Cr.) | 1724.29 | 1534.20 | 1027.01 | 1008.40 | 1085.04 |
| EV / Net Operating Revenue (X) | 0.68 | 0.65 | 0.44 | 0.48 | 0.70 |
| EV / EBITDA (X) | 4.63 | 4.21 | 4.18 | 4.79 | 5.52 |
| MarketCap / Net Operating Revenue (X) | 0.59 | 0.57 | 0.33 | 0.39 | 0.67 |
| Retention Ratios (%) | 50.85 | 56.39 | 39.97 | 4.70 | -4.40 |
| Price / BV (X) | 1.09 | 1.11 | 0.70 | 0.73 | 0.94 |
| Price / Net Operating Revenue (X) | 0.59 | 0.57 | 0.33 | 0.39 | 0.67 |
| EarningsYield | 0.11 | 0.12 | 0.14 | 0.10 | 0.07 |
After reviewing the key financial ratios for Balmer Lawrie Investment Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 10.00 (Mar 24) to 1.00, marking a decrease of 9.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 7.73. This value is within the healthy range. It has decreased from 75.68 (Mar 24) to 7.73, marking a decrease of 67.95.
- For Diluted EPS (Rs.), as of Mar 25, the value is 7.73. This value is within the healthy range. It has decreased from 75.68 (Mar 24) to 7.73, marking a decrease of 67.95.
- For Cash EPS (Rs.), as of Mar 25, the value is 11.82. This value is within the healthy range. It has decreased from 119.31 (Mar 24) to 11.82, marking a decrease of 107.49.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.98. It has decreased from 549.97 (Mar 24) to 61.98, marking a decrease of 487.99.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.98. It has decreased from 549.97 (Mar 24) to 61.98, marking a decrease of 487.99.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 113.81. It has decreased from 1,057.87 (Mar 24) to 113.81, marking a decrease of 944.06.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 16.78. This value is within the healthy range. It has decreased from 164.10 (Mar 24) to 16.78, marking a decrease of 147.32.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.06. This value is within the healthy range. It has decreased from 137.44 (Mar 24) to 14.06, marking a decrease of 123.38.
- For PBT / Share (Rs.), as of Mar 25, the value is 12.87. This value is within the healthy range. It has decreased from 127.51 (Mar 24) to 12.87, marking a decrease of 114.64.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 9.10. This value is within the healthy range. It has decreased from 92.65 (Mar 24) to 9.10, marking a decrease of 83.55.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.73. This value is within the healthy range. It has decreased from 75.68 (Mar 24) to 7.73, marking a decrease of 67.95.
- For PBDIT Margin (%), as of Mar 25, the value is 14.74. This value is within the healthy range. It has decreased from 15.51 (Mar 24) to 14.74, marking a decrease of 0.77.
- For PBIT Margin (%), as of Mar 25, the value is 12.35. This value is within the healthy range. It has decreased from 12.99 (Mar 24) to 12.35, marking a decrease of 0.64.
- For PBT Margin (%), as of Mar 25, the value is 11.30. This value is within the healthy range. It has decreased from 12.05 (Mar 24) to 11.30, marking a decrease of 0.75.
- For Net Profit Margin (%), as of Mar 25, the value is 7.99. This value is within the healthy range. It has decreased from 8.75 (Mar 24) to 7.99, marking a decrease of 0.76.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.79. This value is below the healthy minimum of 8. It has decreased from 7.15 (Mar 24) to 6.79, marking a decrease of 0.36.
- For Return on Networth / Equity (%), as of Mar 25, the value is 12.47. This value is below the healthy minimum of 15. It has decreased from 13.76 (Mar 24) to 12.47, marking a decrease of 1.29.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.47. This value is within the healthy range. It has decreased from 13.21 (Mar 24) to 12.47, marking a decrease of 0.74.
- For Return On Assets (%), as of Mar 25, the value is 5.36. This value is within the healthy range. It has decreased from 5.55 (Mar 24) to 5.36, marking a decrease of 0.19.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.05. This value is within the healthy range. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.81. It has increased from 0.80 (Mar 24) to 0.81, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 2.49. This value is within the healthy range. It has increased from 2.29 (Mar 24) to 2.49, marking an increase of 0.20.
- For Quick Ratio (X), as of Mar 25, the value is 2.22. This value exceeds the healthy maximum of 2. It has increased from 2.02 (Mar 24) to 2.22, marking an increase of 0.20.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 13.09. This value exceeds the healthy maximum of 8. It has increased from 11.79 (Mar 24) to 13.09, marking an increase of 1.30.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 49.14. This value is within the healthy range. It has increased from 43.60 (Mar 24) to 49.14, marking an increase of 5.54.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 36.37. This value is within the healthy range. It has increased from 32.24 (Mar 24) to 36.37, marking an increase of 4.13.
- For Earning Retention Ratio (%), as of Mar 25, the value is 50.86. This value is within the healthy range. It has decreased from 56.40 (Mar 24) to 50.86, marking a decrease of 5.54.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 63.63. This value is within the healthy range. It has decreased from 67.76 (Mar 24) to 63.63, marking a decrease of 4.13.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 14.04. This value is within the healthy range. It has decreased from 16.52 (Mar 24) to 14.04, marking a decrease of 2.48.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.62. This value is within the healthy range. It has decreased from 10.33 (Mar 24) to 8.62, marking a decrease of 1.71.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,724.29. It has increased from 1,534.20 (Mar 24) to 1,724.29, marking an increase of 190.09.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.68, marking an increase of 0.03.
- For EV / EBITDA (X), as of Mar 25, the value is 4.63. This value is below the healthy minimum of 5. It has increased from 4.21 (Mar 24) to 4.63, marking an increase of 0.42.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.59, marking an increase of 0.02.
- For Retention Ratios (%), as of Mar 25, the value is 50.85. This value is within the healthy range. It has decreased from 56.39 (Mar 24) to 50.85, marking a decrease of 5.54.
- For Price / BV (X), as of Mar 25, the value is 1.09. This value is within the healthy range. It has decreased from 1.11 (Mar 24) to 1.09, marking a decrease of 0.02.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.59, marking an increase of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 24) to 0.11, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balmer Lawrie Investment Ltd:
- Net Profit Margin: 7.99%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.47% (Industry Average ROCE: 15.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.47% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8.62
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.22
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 9.84 (Industry average Stock P/E: 112.86)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.05
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.99%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | 21, Netaji Subhas Road, Kolkata West Bengal 700001 | lahoti.a@balmerlawrie.com http://www.blinv.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Saurav Dutta | Non Executive Chairman |
| Mr. Arvind Nath Jha | Government Nominee Director |
| Mr. Samir Kumar Mohanty | Government Nominee Director |